Skip to content

Multiparametric Heart Failure Evaluation in Internal Cardioverter Defibrillators (ICD) Patients

Multiparametric Evaluation of Heart Failure in Device-implanted Patients.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01501331
Acronym
MULTITUDE-HF
Enrollment
180
Registered
2011-12-29
Start date
2011-12-31
Completion date
2014-11-30
Last updated
2014-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Congestive Heart Failure

Keywords

Congestive Heart Failure, Cardiac Resynchronization Therapy, Internal Cardioverter Defibrillators

Brief summary

The Boston Scientific Energen family is capable of measuring the respiratory rate trend (RRT) on a daily basis and transmission of data via the Remote Monitoring technology. This may result in early detection of imminent decompensation at a presymptomatic stage. The study will assess the respiratory trends correlation with clinically relevant heart failure events.

Interventions

DEVICECRTD or ICD (Energen)

RRT measurement by cardiac resynchronization therapy devices and implantable cardioverter defibrillators

Sponsors

University of Rome Tor Vergata
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

* Patient eligible for 1-, 2- or 3-chamber ICD implantation according to current guidelines or patient already implanted within the past 45 days with a Energen device or successor * Able to provide written informed consent

Exclusion criteria

* Life expectancy \<12 months * Anticipated non-compliance with the follow-up scheme * Moderate to severe Chronic Obstructive Pulmonary Disease * Primary pulmonary hypertension

Design outcomes

Primary

MeasureTime frameDescription
Prediction by RRT of cardiovascular death or rehospitalization for worsening of heart failure symptoms.24 monthsRespiratory rate changes (maximum, median and minimum values) before a primary event (3-, 2-, 1-week before and on the day of the event) will be compared to those at baseline (6 weeks prior the event). Pts with less than 30-day of RR data or events without sufficient baseline will be excluded from the analysis

Secondary

MeasureTime frameDescription
Proportion of in-hospital consultations with relevant findings (i.e. necessitating changes in medical therapy, device programming or re-hospitalisations/ interventions)24 monthsRespiratory rate changes (maximum, median and minimum values) before the event (3-, 2-, 1-week before and on the day of the event) will be compared to those at baseline (6 weeks prior the event). Pts with less than 30-day of RR data or events without sufficient baseline will be excluded from the analysis
Correlation of RRT with appropriate ICD therapy (ATP or Shock)24 monthsRespiratory rate changes (maximum, median and minimum values) before the event (3-, 2-, 1-week before and on the day of the event) will be compared to those at baseline (6 weeks prior the event). Pts with less than 30-day of RR data or events without sufficient baseline will be excluded from the analysis
Correlation of RRT with atrial and ventricular arrhythmias24 monthsRespiratory rate changes (maximum, median and minimum values) before the event (3-, 2-, 1-week before and on the day of the event) will be compared to those at baseline (6 weeks prior the event). Pts with less than 30-day of RR data or events without sufficient baseline will be excluded from the analysis

Countries

Italy

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026